The reservoir of an insulin pump contains a predetermined amount of insulin, which is then released into the body's bloodstream through the skin. In order to limit the rise in blood glucose (blood sugar) after a meal, the pumps can deliver modest amounts of insulin continuously (basal) or a bolus dosage just before a meal. The release of insulin by the body is modelled by this delivery. A traditional insulin pump uses a tube to transport insulin from the reservoir to the catheter, whereas tubeless insulin pumps attach to the skin directly. People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia with tubeless insulin pump

The increase in patients suffering from conditions like diabetes as a result of a variety of circumstances, including obesity, being overweight, and a lack of physical activity. As the number of diabetes patients rises, the requirement to maintain an equilibrium between supply and demand for insulin pumps may become a key market driver. Medical practitioners advise using a tubeless insulin pump due to its many benefits over a traditional insulin pump. As many more treatment methods receiving clearance the market for tubeless insulin is expected to boost.Tubeless Insulin Pump Market was valued at US$ 1.87 Billion in 2024 and is projected to grow at a CAGR of 21.30% to reach US$ 12.6 Billion by 2034.

 

The report Tubeless Insulin Pump Market, By Component (Pod/Patch, Remote, and Others), By Distribution Channel (Hospitals, Pharmacies, e-Commerce, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In January 2022, Insulet's Omnipod 5 received FDA approval. The FDA granted approval on January 28, 2022. The newest insulin pump is a high-tech machine that never sleeps and is the only tubeless patch pump. The OmniPod 5 works day and night and guards against insulin highs and lows. Omnipod 5 automated insulin administration device (Insulet Corp) has been given the FDA's approval for use in children with type 1 diabetes 2 years of age and older, the firm said on August 22.

Analyst View:

The rising number of diabetes patients is the main reason propelling the Tubeless Insulin Pump Market. The advantages of tubeless insulin pumps over conventional insulin pumps during the previous few years and in the upcoming year could be a major market driver. The competition between businesses to keep technologically current is anticipated to drive the expansion of the tubeless insulin pump market in the upcoming years.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on Tubeless Insulin Pump Market by Component (Pod/Patch, Remote, and Others), By Distribution Channel (Hospitals, Pharmacies, e-Commerce, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Key Market Insights from the report:

Tubeless Insulin Pump Market was valued at US$ 1.87 Billion in 2024 and is projected to grow at a CAGR of 21.30% to reach US$ 12.6 Billion by 2034. The Tubeless Insulin Pump Market is segmented based on component, distribution channel and region.

• Based on component, Tubeless Insulin Pump Market is segmented into Pod/Patch, Remote, and Others
• Based on Distribution channel, Tubeless Insulin Pump Market is segmented into Hospitals, Pharmacies, e-Commerce, and Others.
• By Region, the Tubeless Insulin Pump Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Tubeless insulin pump market:

The prominent players operating in the Tubeless Insulin Pump Market includes, Insulet Corporation, Johnson & Johnson, Medtrum Technologies, Inc. Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech SA, CeQur SA, Valeritas Holdings, Inc., and Abbott Diabetes Care, Inc.

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com